Submission on the proposed guidelines on pre-implantation genetic testing for cases involving specialist disagreement
27 Oct 2026
Rare Disorders NZ has made a submission on the proposed guidelines on pre-implantation genetic testing for cases involving specialist disagreement.
RDNZ strongly recommends that the Advisory Committee on Assisted Reproductive Technology (ACART) ensure meaningful and ongoing consumer involvement, including representation from people living with rare disorders and their whānau, across any review process.
This aligns with Priority 4 of the Ministry of Health’s 2024 Aotearoa New Zealand Rare Disorders Strategy, "Giving voice to people and their whānau living with rare disorders", which recognises the importance of ensuring that lived-experience perspectives are reflected across the health system.
Read our full submission here.